morphogenesis

Trifluoperazine dihydrochloride (SKF5019) 是一种抗精神病药物，靶向中枢多巴胺受体。它是流感病毒形态发生的可逆抑制剂，是NUPR1抑制剂，具有抗癌活性。它是钙调蛋白抑制剂，还可抑制 P-糖蛋白，可研究精神分裂症。

MGCD-265 analog (Glesatinib) 是一种口服生物可利用的多靶点酪氨酸激酶抑制剂，具有抗肿瘤活性，对 c-Met 和 VEGFR2 的 IC50 分别为 29 nM 和 10 nM。

Trifluoperazine (trifluoroperazine) 是一种多巴胺 D2 受体抑制剂，可治疗精神分裂症。它是NUPR1抑制剂，具有抗癌活性。它是α1-adrenergic 受体拮抗剂，是流感病毒形态发生的可逆抑制剂。

AHR-activator-1023 is the aryl hydrocarbon receptor activator. It is also a specific FGF2-induced branching morphogenesis modulator.

CRT-0066854 is a PKCι and PKCζ inhibitor. CRT0066854 was able to restore polarized morphogenesis in the dysplastic H-Ras spheroids.

IHVR-11029 is a potent inhibitor of ER α-glucosidase. IHVR-11029 is active against multiple hemorrhagic fever viruses and efficiently disrupts the morphogenesis of a broad spectrum of enveloped viruses.

Sphingosine-1-phosphate (S1P) is a bioactive lipid that exhibits a broad spectrum of biological activities including cell proliferation, survival, migration, cytoskeletal organization, and morphogenesis. It exerts its activity by binding to five distinct G protein-coupled receptors, S1P1 EDG-1, S1P2 EDG-5, S1P3 EDG-3, S1P4 EDG-6, and S1P5 EDG-8. W140 is an inactive enantiomer of W146, a selective S1P1 antagonist (Ki = 77 nM), that binds to the S1P1 receptor with a Ki of 4.6 μM (2a = W146; 2b = W140 in supplemental material). It exhibits no biological activity in vivo and can therefore serve as an effective control compound for experiments involving W146.

TCSA is an inhibitor of fungal morphogenesis, biofilm formation, and host cell invasion.

Fusarisetin A 是一种五环真菌代谢物，是一种腺泡形态发生抑制剂。

GRGESP为胶原凝胶收缩抑制剂，能够抑制人成纤维细胞在胶原凝胶中的扩散，显著减少凝胶收缩，适用于结缔组织形态发生研究。